Executive Guidance for AI and Emerging Risks
Hospitals and health systems are rapidly adopting AI-powered tools, connected medical devices, advanced analytics and emerging biotechnology solutions.
Most organizations evaluate these technologies through operational, compliance and cybersecurity lenses. While those considerations remain important, they don’t always address the broader questions facing executive leadership and governing boards, such as:
- What second- and third-order impacts should leaders be considering as artificial intelligence (AI), biotechnology and emerging biotechnologies become more embedded in healthcare?
- How should boards oversee AI adoption, biotechnology and accountability?
- What new dependencies are being created between clinical operations, vendors and data ecosystems?
- How could disruptions in technology supply chains affect patient care?
- How do leaders balance innovation, trust and organizational risk?
As these issues increasingly become matters of governance, risk management and board oversight, the American Hospital Association has partnered with Edward You, president of EHY Consulting, to provide executive-level guidance and strategic perspectives on emerging biotechnologies and organizational risk.
With more than two decades advising the FBI, White House and U.S. intelligence community, Ed brings a rare perspective that bridges science, policy and executive leadership. His work has informed national strategy on biosecurity, emerging technologies and the protection of sensitive health data, and he has advised leading health systems, academic institutions, Fortune 500 organizations, Congress and the United Nations Biological Weapons Convention. View his congressional testimony and appearance on "60 Minutes" discussing issues related to China’s strategy to acquire American health data.
These fee-based services are appropriate for organizations investing in AI and biotechnology that need executive-level dialogue, governance awareness and strategic perspectives surrounding bio-digital risk and emerging clinical technology environments.
Board & Executive Briefings
Through customized sessions, boards and executive teams better understand the opportunities, risks and governance considerations associated with AI, biotechnology and other emerging technologies.
Each briefing is tailored to the organization’s specific priorities, questions and areas of concern, translating complex developments into practical insights that support informed discussions around oversight, strategy and organizational preparedness.
Best suited for organizations seeking to strengthen board and leadership understanding before making significant technology-related decisions.
Leadership Workshops
These facilitated sessions bring executive, clinical and technology leaders together to explore the organizational implications of AI and emerging technology adoption.
These workshops are designed around the organization’s unique circumstances and objectives, encouraging cross-functional dialogue, surfacing critical questions and helping leadership teams think through complex issues before they become operational or governance challenges.
Best suited for organizations actively evaluating, implementing or scaling emerging technologies.
Strategy Advisory Services
For organizations navigating AI, biotechnology and other emerging technologies, Ed serves as a strategic advisor to executive leadership.
These engagements provide access to an experienced outside perspective that can help leaders evaluate emerging risks, identify potential blind spots and better understand the broader implications of technology decisions before they become operational, governance or organizational challenges.
Advisory engagements are shaped by each organization’s priorities, helping leadership teams address the specific questions and considerations most relevant to their environment.
Best suited for organizations seeking ongoing guidance as they evaluate, adopt or scale emerging technologies.
Learn More about Executive Advisory Services for Emerging Risks
Please provide the following information to learn more.